GlassScriptPhysician profile
Hunter J Kraus
NPI 1841868460
$4,285.55
in general payments reported to CMS, 2019-2025
27 companies · $1,126 in 2025
The $1,126 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $324 · 2022: $636 · 2023: $597 · 2024: $1,603 · 2025: $1,126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,733 · Education: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,732.51 |
| Education | $593.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,638.98 | 2022-2025 | Lithovue, Ams 700 Cxr Rte Kit, Ams 700 |
| Astellas Pharma US INC | $612.41 | 2022-2025 | Myrbetriq, Xtandi |
| Medical Device Business Services, INC. | $412.69 | 2021-2024 | |
| Medtronic, INC. | $402.34 | 2023-2025 | Interstim |
| Coloplast Corp | $224.04 | 2024-2025 | |
| Ethicon US, LLC | $117.55 | 2022-2025 | Prolene, Surgicel Nu-Knit, Vistaseal |
| Ferring Pharmaceuticals INC. | $114.40 | 2025 | Adstiladrin |
| Teleflex LLC | $106.41 | 2024-2025 | Deflux Metal Needle, Deflux |
| Axonics, INC. | $87.63 | 2023 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $60.70 | 2023-2025 | Keytruda, Lynparza |
| Endo Pharmaceuticals INC. | $56.67 | 2022-2024 | Xiaflex, Aveed |
| 180 Medical, INC. | $47.13 | 2022-2023 | Gentlecath Glide |
| Endo USA, INC. | $46.93 | 2024-2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $45.94 | 2022-2025 | |
| Procept Biorobotics Corporation | $36.32 | 2024 | Aquabeam System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $34.20 | 2025 | N.A. |
| Convatec INC. | $31.54 | 2022-2023 | |
| Abc Home Medical Supply, INC. | $31.33 | 2025 | |
| Laborie Medical Technologies Corp. | $26.92 | 2023 | |
| Edwards Lifesciences Corporation | $24.44 | 2024 | Hemosphere |
| Vertex Pharmaceuticals Incorporated | $24.27 | 2025 | |
| Palette Life Sciences, INC. | $19.39 | 2023 | |
| Baudax Bio INC. | $19.32 | 2021 | |
| Tolmar, INC. | $18.51 | 2025 | Jatenzo |
| Genmab U.S., INC. | $15.57 | 2024 | Tivdak |
| Abbvie INC. | $15.15 | 2024 | |
| Janssen Pharmaceuticals, INC | $14.77 | 2025 | N/A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Kraus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.